Sign In
Last checked at 
14 Jun 2012 13:33
Hutchison China MediTech Limited ("Chi-Med")
(AIM: HCM)
Exercise of Options
London: Thursday, 14 June 2012: Chi-Med announces that it has issued 192,108 ordinary shares of US$1.00 each (the "Shares") following the exercise of options by Mr Johnny Cheng, Executive Director and Chief Financial Officer of Chi-Med, at an exercise price of GBP1.26 per share on 14 June 2012.
Following the issue of the Shares, Mr Cheng is beneficially interested in 192,108 Shares, representing approximately 0.37% of the current issued share capital of Chi-Med.
Ends
Enquiries
Chi-Med Christian Hogg, CEO | Telephone: +852 2121 8200 |
Citigate Dewe Rogerson Anthony Carlisle David Dible | Telephone: +44 20 7638 9571 Mobile: +44 7973 611 888 Mobile: +44 7967 566 919 |
Lazard & Co., Limited Paul Gismondi Nick Fowler | Telephone: +44 20 7187 2000
|
About Chi-Med
Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.
Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.
Follow the stocks
